Free Newsletter
Clerics rule on vaccine containing pig material
In Indonesia, pig components can make the difference between market acceptance and rejection of a vaccine--but by a higher authority than regulators. The country's top Muslim clerical body has declared two brands of meningitis vaccine as halal, or lawful, thanks to the absence of pig components in their production. The vaccines, made by Novartis and China's Tian Yuana, are therefore allowed for use by Muslims on pilgrimage to Mecca. The approval follows visits by members of the clerical body, The Indonesian Ulema Council, to the vaccine plants.
Saudi Arabia requests that haj pilgrims carry a certificate proving they've been vaccinated.
Muslims had long been using a GlaxoSmithKline vaccine, which the clerics say contains traces of pig products. Lack of alternatives and an emergency declaration led to a bypass of the rule. But the vaccine was declared haraam two years ago, forbidden for pre-haj use. The vaccine itself has no traces of swine elements, the clerics say, but the production process includes their use.
Pig components are not considered haraam in the U.S. vaccine business. But a couple of vaccines had a close call earlier this year when regulators called a temporary halt to the use of a GSK rotavirus vaccine found to contain pig virus DNA. A similar discovery was made in a Merck rotavirus vaccine, but it was not subject to the halt because by then scientists had ruled out a safety risk.
- here's the article
Related Articles:
Pig virus contamination halts GSK Rotarix use
Drugmakers: Trypsin likely culprit in Rotavirus vax contamination
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: